NovaTract Surgical develops medical devices for single incision laparoscopic and natural orifice transluminal endoscopic surgeries.
NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 28, 2015 | Debt Financing | — | 1 | — | — | Detail |
Jun 25, 2012 | Series A | $2.37M | 1 | — | — | Detail |
May 31, 2012 | Series Unknown | $327.25K | 1 | — | — | Detail |
Mar 16, 2011 | Seed | $150K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Advantage Capital | — | Debt Financing |